Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

Santen Pharmaceutical Co., Ltd. SNPHY

Set alert

Price alert · SNPHY

All alert types
11.23 USD +0.45 +4.17%

At close · Oct 30

11.82 Day range 11.82
9.62 52-week range 13.90
YTD
+9.03%
1 year
+13.66%
Open
11.82
Prev close
10.78
Mkt cap
3.61B
Vol
4
Avg vol
2.35K
EPS
0.77
P/E
14.58
More statistics
Low
11.82
High
11.82

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for SNPHY has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

5.23 Safe zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

8 / 9 Strong

Nine pass/fail tests of profitability, leverage and efficiency.

FMP rating

A4 / 5 overall

  • DCF 4
  • Return on Equity 4
  • Return on Assets 5
  • Debt / Equity 3
  • P/E 3
  • P/B 3

Valuation

P/E 14.5×
FY 2017: 30.5×FY 2018: 20.6×FY 2019: 21.5×FY 2020: 30.9×FY 2021: 89.8×FY 2022: 17.8×FY 2023: -29.1×FY 2024: 19.6×FY 2025: 13.7×FY 2026: 14.5×
FY 2017 5y median 14.5× FY 2026
P/S 1.9×
FY 2017: 3.3×FY 2018: 3.2×FY 2019: 2.9×FY 2020: 3.0×FY 2021: 2.5×FY 2022: 1.8×FY 2023: 1.6×FY 2024: 1.7×FY 2025: 1.7×FY 2026: 1.9×
FY 2017 5y median 1.7× FY 2026
P/B 1.9×
FY 2017: 2.6×FY 2018: 2.5×FY 2019: 2.4×FY 2020: 2.4×FY 2021: 2.0×FY 2022: 1.4×FY 2023: 1.5×FY 2024: 1.7×FY 2025: 1.7×FY 2026: 1.9×
FY 2017 5y median 1.7× FY 2026
P/FCF 14.9×
FY 2017: 493×FY 2018: 22.0×FY 2019: 28.0×FY 2020: 23.7×FY 2021: 40.9×FY 2022: 47.6×FY 2023: 34.6×FY 2024: 8.4×FY 2025: 9.1×FY 2026: 14.9×
FY 2017 5y median 14.9× FY 2026
EV/EBITDA 7.9×
FY 2017: 14.6×FY 2018: 13.3×FY 2019: 10.9×FY 2020: 12.7×FY 2021: 8.0×FY 2022: 8.2×FY 2023: 31.9×FY 2024: 9.1×FY 2025: 6.4×FY 2026: 7.9×
FY 2017 5y median 8.2× FY 2026
EV/Sales 1.7×
FY 2017: 3.1×FY 2018: 2.9×FY 2019: 2.7×FY 2020: 2.7×FY 2021: 2.2×FY 2022: 1.6×FY 2023: 1.5×FY 2024: 1.5×FY 2025: 1.5×FY 2026: 1.7×
FY 2017 5y median 1.5× FY 2026
FCF Yield 6.7%
FY 2017: 0.2%FY 2018: 4.5%FY 2019: 3.6%FY 2020: 4.2%FY 2021: 2.4%FY 2022: 2.1%FY 2023: 2.9%FY 2024: 11.9%FY 2025: 11.0%FY 2026: 6.7%
FY 2017 5y median 6.7% FY 2026

Profitability

Gross Margin 55.2%
FY 2017: 62.3%FY 2018: 61.6%FY 2019: 61.2%FY 2020: 60.7%FY 2021: 60.6%FY 2022: 58.8%FY 2023: 59.5%FY 2024: 59.2%FY 2025: 57.0%FY 2026: 55.2%
FY 2017 5y median 58.8% FY 2026
Operating Margin 15.5%
FY 2017: 16.3%FY 2018: 17.2%FY 2019: 19.3%FY 2020: 13.9%FY 2021: 15.1%FY 2022: 13.5%FY 2023: -1.1%FY 2024: 12.8%FY 2025: 15.6%FY 2026: 15.5%
FY 2017 5y median 13.5% FY 2026
Net Margin 12.8%
FY 2017: 10.9%FY 2018: 15.7%FY 2019: 13.7%FY 2020: 9.8%FY 2021: 2.7%FY 2022: 10.2%FY 2023: -5.4%FY 2024: 8.8%FY 2025: 12.1%FY 2026: 12.8%
FY 2017 5y median 10.2% FY 2026
ROE 13.3%
FY 2017: 8.6%FY 2018: 12.3%FY 2019: 11.0%FY 2020: 7.8%FY 2021: 2.2%FY 2022: 8.1%FY 2023: -5.1%FY 2024: 8.7%FY 2025: 12.7%FY 2026: 13.3%
FY 2017 5y median 8.7% FY 2026
ROIC 11.2%
FY 2017: 8.7%FY 2018: 10.7%FY 2019: 10.1%FY 2020: 6.7%FY 2021: 6.2%FY 2022: 7.2%FY 2023: -0.9%FY 2024: 10.0%FY 2025: 10.9%FY 2026: 11.2%
FY 2017 5y median 10.0% FY 2026
ROA 9.3%
FY 2017: 6.7%FY 2018: 9.1%FY 2019: 8.2%FY 2020: 5.8%FY 2021: 1.7%FY 2022: 5.9%FY 2023: -3.5%FY 2024: 6.1%FY 2025: 8.9%FY 2026: 9.3%
FY 2017 5y median 6.1% FY 2026

Growth (YoY)

Revenue 3.1%
FY 2017: 1.9%FY 2018: 13.0%FY 2019: 4.0%FY 2020: 3.2%FY 2021: 3.3%FY 2022: 6.7%FY 2023: 4.8%FY 2024: 8.2%FY 2025: -0.6%FY 2026: 3.1%
FY 2017 FY 2026
Operating Income 2.3%
FY 2017: -59.5%FY 2018: 19.1%FY 2019: 16.6%FY 2020: -25.6%FY 2021: 12.7%FY 2022: -5.1%FY 2023: -108.6%FY 2024: 1347.3%FY 2025: 21.6%FY 2026: 2.3%
FY 2017 FY 2026
EPS (diluted) 17.1%
FY 2017: -58.9%FY 2018: 63.9%FY 2019: -9.3%FY 2020: -24.8%FY 2021: -71.1%FY 2022: 298.4%FY 2023: -156.8%FY 2024: 287.6%FY 2025: 43.3%FY 2026: 17.1%
FY 2017 FY 2026
Free Cash Flow -28.4%
FY 2017: -90.0%FY 2018: 2350.2%FY 2019: -25.4%FY 2020: 25.1%FY 2021: -51.2%FY 2022: -32.0%FY 2023: 23.1%FY 2024: 393.4%FY 2025: -12.4%FY 2026: -28.4%
FY 2017 FY 2026

Financial Health

Current Ratio 2.6×
FY 2017: 2.9×FY 2018: 2.9×FY 2019: 3.2×FY 2020: 3.2×FY 2021: 2.6×FY 2022: 2.4×FY 2023: 2.4×FY 2024: 2.5×FY 2025: 2.6×FY 2026: 2.6×
FY 2017 5y median 2.5× FY 2026
Quick Ratio 1.9×
FY 2017: 2.4×FY 2018: 2.5×FY 2019: 2.6×FY 2020: 2.7×FY 2021: 2.1×FY 2022: 2.0×FY 2023: 1.9×FY 2024: 2.1×FY 2025: 2.0×FY 2026: 1.9×
FY 2017 5y median 2.0× FY 2026
Debt / Equity 0.1×
FY 2017: 0.1×FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.1×FY 2023: 0.1×FY 2024: 0.1×FY 2025: 0.1×FY 2026: 0.1×
FY 2017 5y median 0.1× FY 2026
Net Debt / EBITDA -0.7×
FY 2017: -0.8×FY 2018: -1.2×FY 2019: -1.2×FY 2020: -1.5×FY 2021: -0.8×FY 2022: -0.9×FY 2023: -1.7×FY 2024: -1.2×FY 2025: -0.9×FY 2026: -0.7×
FY 2017 5y median -0.9× FY 2026
Interest Coverage 22.7×
FY 2017: 20.8×FY 2018: 89.1×FY 2019: 15.7×FY 2020: 14.0×FY 2021: 25.4×FY 2022: 29.7×FY 2023: -2.1×FY 2024: 14.5×FY 2025: 17.3×FY 2026: 22.7×
FY 2017 5y median 17.3× FY 2026

Dividends

Dividend Yield 2.3%
FY 2017: 1.6%FY 2018: 1.5%FY 2019: 1.5%FY 2020: 1.4%FY 2021: 1.8%FY 2022: 2.5%FY 2023: 2.9%FY 2024: 2.3%FY 2025: 2.4%FY 2026: 2.3%
FY 2017 5y median 2.4% FY 2026
Payout Ratio 33.8%
FY 2017: 49.5%FY 2018: 29.9%FY 2019: 33.1%FY 2020: 43.9%FY 2021: 163.8%FY 2022: 44.1%FY 2023: -84.3%FY 2024: 44.6%FY 2025: 33.4%FY 2026: 33.8%
FY 2017 5y median 33.8% FY 2026

Annual · latest fiscal year ends 2026-03-31